Delivery Order SPE2DB22D9316-SPE2DB25FYP58
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,167.36 contract is for the supply of Nplate 250 mcg vials, with a period of performance ending on October 15, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,472.80, is for the delivery of Nplate 250 mcg vials. It has an ultimate completion date of November 29, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NPLATE 250 MCG VIALS. The contract, valued at $10,167.36, has an ultimate completion date of June 20, 2024 and was awarded on May 29, 2024. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to the U.S. federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, with a ceiling value of $10,167.36 and an ultimate completion date of October 3, 2024, is for the delivery of pharmaceutical products, including Nplate 250 mcg vials. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, supporting the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,694.68 contract is for the delivery of NPLATE 250 MCG VIALS, a specialized pharmaceutical product, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, worth $16,945.60, is for the supply of NPLATE 250 MCG VIALS and has a completion date of February 22, 2024. DMS Pharmaceutical Group is an experienced prime contractor for DLA, holding a multi-year indefinite delivery contract valued up to $4,999,999 to provide a wide range of pharmaceuticals and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $15,567 to supply 250 mcg vials of Nplate to the Defense Logistics Agency under an indefinite delivery contract. As a woman-owned small business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various contracts with the Defense Logistics Agency to provide prescription drugs and medical supplies in support of military treatment facilities worldwide. This delivery order for Nplate...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $21,874.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NPLATE 250 MCG VIALS, with a performance period ending on May 14, 2024. This delivery order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with DLA, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,096.04, is for the delivery of NPLATE 250 MCG VIALS and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,167.36, is for the delivery of NPLATE 250 MCG VIALS medical supplies. The contract has no set-aside designation and runs through May 13, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award indefinite delivery contract (IDC) with the...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP58Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the contractor to compete on an unrestricted basis. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.999 billion and valid through November 2026. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides comprehensive pharmaceutical distribution services to Department of Defense healthcare facilities nationwide. The contractor's portfolio includes an extensive range of branded and generic prescription drugs, biologics, medical consumables, and specialized pharmaceutical products. Nplate (romiplostim) is a thrombopoietin receptor agonist used to treat immune thrombocytopenia, representing the specialized medical products critical to military health system operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 7/21/25 |